Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Femoral Nerve Block in TKA
NCT02341079Phase 3Withdrawn
- Sponsor
- Naval Medical Center San Diego
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Naval Medical Center San Diego. Primary endpoints: Visual Analog Pain Scale, Oral and Intravenous Opioid Consumption and 1 more. Planned start Mar 2015; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02341079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341079.